Amsterdam, Netherlands

Ana Fernadez Casares


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Ana Fernadez Casares

Introduction: Ana Fernadez Casares is a distinguished inventor based in Amsterdam, NL, celebrated for her significant contributions to pharmaceutical innovations. With a passion for developing advanced medical solutions, she has made her mark in the field of drug formulation.

Latest Patents: Ana holds one patent titled "Ibrutinib solid forms and production process therefor." This patent introduces novel polymorphs of Ibrutinib, including crystalline forms III, IV, V, VI, VII, VIII, and IX. It also encompasses processes for the production of these crystalline forms as well as stable amorphous Ibrutinib. Additionally, her work includes pharmaceutical compositions containing these forms and methods for utilizing both the crystalline and amorphous variants in therapeutic applications.

Career Highlights: Ana works at Perrigo API Ltd., where she continues to push the boundaries of innovation in the pharmaceutical sector. Her expertise and dedication to research have established her as a valued member of the team, contributing to the progress of medicinal chemistry and pharmaceutical development.

Collaborations: Throughout her career, Ana has collaborated with talented coworkers, including Itai Adin and Sonia Krivonos. These collaborations have fostered a dynamic environment for exchanging ideas and driving forward impactful research initiatives in the field of pharmaceuticals.

Conclusion: Ana Fernadez Casares is an exemplary figure in the world of innovation, highlighting the importance of continual advancement in medical science. Her pioneering work on Ibrutinib solid forms is poised to have a significant impact on patient care, showcasing her commitment to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…